Exact Mass: 427.2635

Exact Mass Matches: 427.2635

Found 393 metabolites which its exact mass value is equals to given mass value 427.2635, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ranolazine

N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide

C24H33N3O4 (427.2471)


Ranolazine is only found in individuals that have used or taken this drug. It is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]The mechanism of action of ranolazine is unknown. It does not increase the rate-pressure product, a measure of myocardial work, at maximal exercise. In vitro studies suggest that ranolazine is a P-gp inhibitor. Ranolazine is believed to have its effects via altering the trans-cellular late sodium current. It is by altering the intracellular sodium level that ranolazine affects the sodium-dependent calcium channels during myocardial ischemia. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia. C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Dihydroxyacidissiminol

N-[2-(4-{[(2E)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidate

C25H33NO5 (427.2359)


Dihydroxyacidissiminol is found in beverages. Dihydroxyacidissiminol is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Dihydroxyacidissiminol is found in beverages and fruits.

   

N-Linoleoyl Phenylalanine

2-(octadeca-9,12-dienamido)-3-phenylpropanoic acid

C27H41NO3 (427.3086)


N-linoleoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Phenylalanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Valine

2-(docosa-4,7,10,13,16,19-hexaenamido)-3-methylbutanoic acid

C27H41NO3 (427.3086)


N-docosahexaenoyl valine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Valine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Valine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Valine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Dixyrazine

2-[2-(4-{2-[(10H-phenothiazin-10-yl)methyl]propyl}piperazin-1-yl)ethoxy]ethan-1-ol

C24H33N3O2S (427.2293)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000932 - Antiemetics

   

Mozavaptan

N-{4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]phenyl}-2-methylbenzamide

C27H29N3O2 (427.226)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

   

Peimisine

5-hydroxy-2,3,6,15-tetramethyl-3a,4,5,6,7,7a-hexahydro-3H-spiro[furo[3,2-b]pyridine-2,14-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadecan]-15-en-8-one

C27H41NO3 (427.3086)


   

Pimavanserin

Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-n-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)

C25H34FN3O2 (427.2635)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

Valyl-prolyl-glycyl-valyl-glycine

2-[(2-{[2-({[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxyethylidene]amino}-1-hydroxy-3-methylbutylidene)amino]acetate

C19H33N5O6 (427.2431)


   

Peimisine

Spiro[9H-benzo[a]fluorene-9,2(3H)-furo[3,2-b]pyridin]-5(6H)-one, 1,2,3,3a,4,4,4a,5,6,6a,6b,7,7,7a,8,11,11a,11b-octadecahydro-3-hydroxy-3,6,10,11b-tetramethyl-, (2R,3S,3R,3aS,4aS,6S,6aR,6bS,7aR,11aS,11bR)-

C27H41NO3 (427.3086)


Peimisine is an alkaloid. Peimisine is a natural product found in Fritillaria anhuiensis, Fritillaria cirrhosa, and other organisms with data available. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   

Lasiocarpine N-oxide

Lasiocarpine N-oxide

C21H33NO8 (427.2206)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2306

   
   
   

Acetylstachyflin

Acetylstachyflin

C25H33NO5 (427.2359)


   

Cytochalasin Z13

Cytochalasin Z13

C25H33NO5 (427.2359)


   

Huperserratinine

Huperserratinine

C25H33NO5 (427.2359)


   

Memnobotrin A

Memnobotrin A

C25H33NO5 (427.2359)


   

Peimisine

(3S,3R,3aS,4aS,6S,6aR,6bS,7aR,9R,11aS,11bR)-3-hydroxy-3,6,10,11b-tetramethyl-spiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[4,5-b]pyridine]-5-one

C27H41NO3 (427.3086)


Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3]. Peimisine (Ebeiensine) is a muscarinic M receptor antagonist and angiotensin converting enzyme (ACE) inhibitor. Peimisine shows anti-tumor, anti-inflammatory, antihypertensive activities. Peimisine can induce apoptosis and be used in cough and asthma research[1][2][3].

   

Solaspiralidine

Solaspiralidine

C27H41NO3 (427.3086)


   

Subdaphnidine A

Subdaphnidine A

C25H33NO5 (427.2359)


   

Cytochalasin Z11

Cytochalasin Z11

C25H33NO5 (427.2359)


   

Geyerine

6-Hydroxy-11-O-(2-methylbutanoyl)hetisinone

C25H33NO5 (427.2359)


   

Daphmanidin A

Daphmanidin A

C25H33NO5 (427.2359)


   

Arachidonoyl ethanolamide phosphate

Arachidonoyl ethanolamide phosphate

C22H38NO5P (427.2487)


   
   

Dixyrazine

Dixyrazine

C24H33N3O2S (427.2293)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); CONFIDENCE Reference Standard (Level 1)

   

cytochalasin Z15

cytochalasin Z15

C25H33NO5 (427.2359)


   

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

(3R*,4S*,5S*,6S*,8R*,10R*)-3-[1,2,4a,5,6,7,8,8a-octahydro-3,6,8-trimethyl-2-[(E)-1-methyl-1-propenyl]-1-naphthalenyl]carbonyl-5-butoxy-1,5-dihydro-5-methyl-2H-pyrrol-2-one|ascosalipyrrolidinone A

C27H41NO3 (427.3086)


   

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

(25R)-23,26-epimino-3beta-hydroxy-5alpha-cholest-23(N)-ene-6,22-dione

C27H41NO3 (427.3086)


   
   
   

Veralodisinol

Veralodisinol

C27H41NO3 (427.3086)


   

(1aS,2aS,5S,5aS,6S,6aR)-5-benzylhexahydro-2a-hydroxy-2-[(1E,4S,6S)-6-hydroxy-4-methyl-5-oxohept-1-enyl]-6,6a-dimethyl-3H-oxireno[f]isoindol-3-one|cytochalasin Z20

(1aS,2aS,5S,5aS,6S,6aR)-5-benzylhexahydro-2a-hydroxy-2-[(1E,4S,6S)-6-hydroxy-4-methyl-5-oxohept-1-enyl]-6,6a-dimethyl-3H-oxireno[f]isoindol-3-one|cytochalasin Z20

C25H33NO5 (427.2359)


   

myceliothermophin C

myceliothermophin C

C27H41NO3 (427.3086)


   

verticilactam

verticilactam

C25H33NO5 (427.2359)


   

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

12beta-hydroxy-(25S)-22betaN-spirosol-4-en-3-one

C27H41NO3 (427.3086)


   
   

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

(23R)-17,23-epoxy-veratra-5,12-diene-3beta,11beta-diol|deoxojervin-11beta-ol|Servin-11beta-ol|Veratrobasin

C27H41NO3 (427.3086)


   

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

(20Xi,23Xi,25Xi,26Xi)-23,26-epoxy-3beta-hydroxy-(5alpha)-16,28-seco-solanid-22(28)-en-6-one|Korsevinin|korsevinine

C27H41NO3 (427.3086)


   

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

Brachystamide E|brachystamide-E|N-isobutyl-16-(3,4-methylenedioxyphenyl)-2E,4E-hexadecadienamide

C27H41NO3 (427.3086)


   

Leu Gly Ala Pro Gly

Leu Gly Ala Pro Gly

C19H33N5O6 (427.2431)


   

arginylprolylarginine

arginylprolylarginine

C17H33N9O4 (427.2655)


   

Lasiocarpine N-oxide

2-BUTENOIC ACID, 2-METHYL-, 7-((2,3-DIHYDROXY-2-(1-METHOXYETHYL)-3-METHYL-1-OXOBUTOXY)METHYL)-2,3,5,7A-TETRAHYDRO-1H-PYRROLIZIN-1-YL ESTER, N-OXIDE, (1S-(1.ALPHA.(Z),7(S*(R*)),7A.ALPHA.))-

C21H33NO8 (427.2206)


Lasiocarpine N-oxide is a natural product found in Heliotropium hirsutissimum and Heliotropium ellipticum with data available.

   

RANOLAZINE

N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide

C24H33N3O4 (427.2471)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

(2R,2R,4aS,6R,8aS)-4-hydroxy-2,5,5,8a-tetramethyl-6-oxo-3,3,4,4a,5,6,6,7,7,8,8,8a-dodecahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6-yl acetate

(2R,2R,4aS,6R,8aS)-4-hydroxy-2,5,5,8a-tetramethyl-6-oxo-3,3,4,4a,5,6,6,7,7,8,8,8a-dodecahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6-yl acetate

C25H33NO5 (427.2359)


   

Sipeimone

Sipeimone

C27H41NO3 (427.3086)


Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Veratrum alkaloids

   

Ala Ile Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Ile Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Ile Pro Gln

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ala Ile Gln Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ala Lys Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Lys Leu Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Lys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Lys Pro Leu

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Leu Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ala Leu Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Leu Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ala Leu Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ala Pro Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Ile Gln

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ala Pro Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Lys Leu

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Leu Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ala Pro Leu Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ala Pro Gln Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Ala Pro Gln Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Ala Gln Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ala Gln Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ala Gln Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Ala Gln Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Gly His Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

Gly His Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]hexanoic acid

C17H29N7O6 (427.2179)


   

Gly Lys His Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

Gly Lys Ser His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Gly Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Gly Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543)


   

Gly Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Gly Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

Gly Ser His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C17H29N7O6 (427.2179)


   

Gly Ser Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Gly Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543)


   

Gly Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

His Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

His Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C17H29N7O6 (427.2179)


   

His Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

His Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C17H29N7O6 (427.2179)


   

His Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C17H29N7O6 (427.2179)


   

His Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C17H29N7O6 (427.2179)


   

Ile Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ile Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Ile Ala Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ile Ala Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   
   

Ile Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Ile Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Ile Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Ile Pro Ala Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Ile Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Ile Pro Gln Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Ile Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ile Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O6 (427.2431)


   
   

Lys Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ala Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Ala Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Gly His Ser

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

Lys Gly Ser His

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Lys His Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxypropanoic acid

C17H29N7O6 (427.2179)


   

Lys His Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]acetic acid

C17H29N7O6 (427.2179)


   

Lys Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Ile Pro Ala

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Lys Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Lys Leu Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Ile Ala

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Leu Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Lys Pro Pro Ser

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C19H33N5O6 (427.2431)


   

Lys Pro Ser Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Lys Ser Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Lys Ser His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N7O6 (427.2179)


   

Lys Ser Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Leu Ala Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Leu Ala Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O5 (427.2795)


   

Leu Ala Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Leu Ala Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Leu Lys Ala Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O5 (427.2795)


   

Leu Lys Pro Ala

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H37N5O5 (427.2795)


   

Leu Pro Ala Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Leu Pro Ala Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-carbamoylbutanoic acid

C19H33N5O6 (427.2431)


   

Leu Pro Lys Ala

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Leu Pro Gln Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Leu Gln Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Leu Gln Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O6 (427.2431)


   
   

Asn Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Asn Val Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Asn Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Pro Ala Ile Lys

(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Ile Gln

(2S)-4-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]butanoic acid

C19H33N5O6 (427.2431)


   

Pro Ala Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Leu Lys

(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ala Leu Gln

(2S)-4-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]butanoic acid

C19H33N5O6 (427.2431)


   

Pro Ala Gln Ile

(2S,3S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Pro Ala Gln Leu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Pro Gly Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Pro Gly Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]pentanoic acid

C18H33N7O5 (427.2543)


   

Pro Ile Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Ile Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]butanoic acid

C19H33N5O6 (427.2431)


   

Pro Ile Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Ile Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Pro Lys Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanamido]-3-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Ala Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]propanamido]-4-methylpentanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Leu Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-methylpentanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Lys Pro Ser

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C19H33N5O6 (427.2431)


   

Pro Lys Ser Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Pro Leu Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O5 (427.2795)


   

Pro Leu Ala Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]butanoic acid

C19H33N5O6 (427.2431)


   

Pro Leu Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]propanoic acid

C20H37N5O5 (427.2795)


   

Pro Leu Gln Ala

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Pro Asn Val Val

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Pro Pro Lys Ser

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]-3-hydroxypropanoic acid

C19H33N5O6 (427.2431)


   

Pro Pro Ser Lys

(2S)-6-amino-2-[(2S)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]hexanoic acid

C19H33N5O6 (427.2431)


   

Pro Gln Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Pro Gln Ala Leu

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Pro Gln Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylpentanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Pro Gln Leu Ala

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-methylpentanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Pro Arg Gly Val

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Pro Arg Val Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]acetic acid

C18H33N7O5 (427.2543)


   

Pro Ser Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Pro Ser Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O6 (427.2431)


   

Pro Val Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}pentanoic acid

C18H33N7O5 (427.2543)


   

Pro Val Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Pro Val Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]acetic acid

C18H33N7O5 (427.2543)


   

Pro Val Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Gln Ala Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Gln Ala Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Gln Ala Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Gln Ala Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Gln Ile Ala Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Gln Ile Pro Ala

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O6 (427.2431)


   

Gln Leu Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Gln Leu Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C19H33N5O6 (427.2431)


   

Gln Pro Ala Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Gln Pro Ala Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C19H33N5O6 (427.2431)


   

Gln Pro Ile Ala

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Gln Pro Leu Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]propanoic acid

C19H33N5O6 (427.2431)


   

Arg Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Arg Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

Arg Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C18H33N7O5 (427.2543)


   

Arg Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C18H33N7O5 (427.2543)


   

Arg Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

Arg Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N7O5 (427.2543)


   

Ser Gly His Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C17H29N7O6 (427.2179)


   

Ser Gly Lys His

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Ser His Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanoic acid

C17H29N7O6 (427.2179)


   

Ser His Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetic acid

C17H29N7O6 (427.2179)


   

Ser Lys Gly His

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C17H29N7O6 (427.2179)


   

Ser Lys His Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C17H29N7O6 (427.2179)


   

Ser Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ser Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Ser Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O6 (427.2431)


   

Val Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543)


   

Val Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

Val Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Val Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Val Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543)


   

Val Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C19H33N5O6 (427.2431)


   

Val Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C18H33N7O5 (427.2543)


   

Val Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C19H33N5O6 (427.2431)


   

Val Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543)


   

Val Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N7O5 (427.2543)


   

Val Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O6 (427.2431)


   

Val Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C19H33N5O6 (427.2431)


   

Anandamide 0-phosphate

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine-O-phosphate

C22H38NO5P (427.2487)


   

20-hydroxy N-Arachidonoyl Taurine

20-hydroxy-2-[(1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl)amino]-ethane sulfonic acid

C22H37NO5S (427.2392)


   

cyclopropyl amide

N-ethyl-9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-cyclopropyl amide

C26H37NO4 (427.2722)


   

PGF2&alpha

N-[(2-hydroxy-1-hydroxymethyl)ethyl]-9α,11α,15S-trihydroxy-prosta-5Z,13E-dien-1-amide

C23H41NO6 (427.2934)


   

PGF2alpha-dihydroxypropanylamine

N-(1,3-dihydroxypropan-2-yl)-9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl amine

C23H41NO6 (427.2934)


   

15-HETE-T

N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-taurine

C22H37NO5S (427.2392)


   

12-HETE-T

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-taurine

C22H37NO5S (427.2392)


   

Dihydroxyacidissiminol

N-[2-(4-{[(2E)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzamide

C25H33NO5 (427.2359)


   

Anandamide O-phosphate

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine-O-phosphate

C22H38NO5P (427.2487)


   

7-(2,2-Diphenylethenyl)-1,2,3,3A,4,8B-hexahydro-4-(4-methylphenyl)cyclopent[B]indole

7-(2,2-Diphenylethenyl)-1,2,3,3A,4,8B-hexahydro-4-(4-methylphenyl)cyclopent[B]indole

C32H29N (427.23)


   

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

dioctyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

C20H46NO6P (427.3063)


   

Pentaerythritol tris-[3-(1-aziridinyl)-propionate]

Pentaerythritol tris-[3-(1-aziridinyl)-propionate]

C20H33N3O7 (427.2318)


   

(-)-n-dodecyl-n-methylephedrinium bromide

(-)-n-dodecyl-n-methylephedrinium bromide

C23H42BrNO (427.245)


   

bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate

bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate

C12H36BF4N7P2 (427.2536)


   

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

2-(tert-butylamino)ethyl 2-methylprop-2-enoate,butyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C23H41NO6 (427.2934)


   
   

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

C21H42NNaO4S (427.2732)


   

N,N-Bis[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide

N,N-Bis[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide

C28H29NO3 (427.2147)


   

Benzoic acid, 4-[[(5-ethoxy-5-oxopentyl)[2-(2-Methoxyphenyl)ethyl]aMino]Methyl]-, Methyl ester

Benzoic acid, 4-[[(5-ethoxy-5-oxopentyl)[2-(2-Methoxyphenyl)ethyl]aMino]Methyl]-, Methyl ester

C25H33NO5 (427.2359)


   

Ivaltinostat

Ivaltinostat

C24H33N3O4 (427.2471)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   
   

7-(4-Benzylpiperazin-1-yl)-3-(2-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine

7-(4-Benzylpiperazin-1-yl)-3-(2-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine

C26H29N5O (427.2372)


   

(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid

(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid

C18H33N7O5 (427.2543)


   

N-[4-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]phenyl]-4-propylbenzenesulfonamide

N-[4-[[4-(cyclopropylmethyl)piperazin-1-yl]methyl]phenyl]-4-propylbenzenesulfonamide

C24H33N3O2S (427.2293)


   

3,24-Dioxo-cholest-4-en-26-oate

3,24-Dioxo-cholest-4-en-26-oate

C27H39O4- (427.2848)


   

Protoansatrienin

Protoansatrienin

C25H33NO5 (427.2359)


   

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

[4-[[(2S)-1-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentyl]-(diaminomethylidene)azanium

C20H39N6O4+ (427.3033)


   

[3-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-8-azaniumyloctyl]azanium

[3-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-8-azaniumyloctyl]azanium

C18H33N7O3S+2 (427.2365)


   

methyl (1S,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1S,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C24H31N2O5+ (427.2233)


   

N-Linoleoyl Phenylalanine

N-Linoleoyl Phenylalanine

C27H41NO3 (427.3086)


   

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-methylbutanoic acid

C27H41NO3 (427.3086)


   
   

N-[[4-(2-ethoxyphenyl)-1-piperazinyl]-sulfanylidenemethyl]-1-adamantanecarboxamide

N-[[4-(2-ethoxyphenyl)-1-piperazinyl]-sulfanylidenemethyl]-1-adamantanecarboxamide

C24H33N3O2S (427.2293)


   

4-[(4-Cyclohexyl-1-piperazinyl)-oxomethyl]-2-ethyl-6,7-dimethoxy-1-isoquinolinone

4-[(4-Cyclohexyl-1-piperazinyl)-oxomethyl]-2-ethyl-6,7-dimethoxy-1-isoquinolinone

C24H33N3O4 (427.2471)


   

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

C25H34FN3O2 (427.2635)


   
   

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

C17H33N9O4 (427.2655)


   

N-(1-cyclohexyl-3-hydroxy-3,4-diphenylbutyl)benzamide

N-(1-cyclohexyl-3-hydroxy-3,4-diphenylbutyl)benzamide

C29H33NO2 (427.2511)


   

N-Benzylidene-1-amino(hepta)ethyleneglycol monomethyl ether

N-Benzylidene-1-amino(hepta)ethyleneglycol monomethyl ether

C22H37NO7 (427.257)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

C22H29N5O4 (427.2219)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

C22H29N5O4 (427.2219)


   

N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide

C22H29N5O4 (427.2219)


   

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]oxan-2-yl]acetamide

C20H33N3O5S (427.2141)


   

(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H33N3O4 (427.2471)


   

N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H33N3O4 (427.2471)


   

1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone

1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone

C24H33N3O4 (427.2471)


   

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C22H29N5O4 (427.2219)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C22H29N5O4 (427.2219)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C22H29N5O4 (427.2219)


   

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methylphenyl)sulfonylamino]-2-oxanyl]acetamide

C20H33N3O5S (427.2141)


   

1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone

1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone

C24H33N3O4 (427.2471)


   
   
   

14-(Methoxycarbonyl)-4,4,8alpha,12,16-pentamethyl-3,17-dioxo-5beta,9beta,10alpha,13alpha-androsta-11,15-dien-15-olate

14-(Methoxycarbonyl)-4,4,8alpha,12,16-pentamethyl-3,17-dioxo-5beta,9beta,10alpha,13alpha-androsta-11,15-dien-15-olate

C26H35O5- (427.2484)


   

Deoxynivalenol 10-leucine

Deoxynivalenol 10-leucine

C21H33NO8 (427.2206)


   

Deoxynivalenol 10-isoleucine

Deoxynivalenol 10-isoleucine

C21H33NO8 (427.2206)


   

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

(2E)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]octadec-2-enoate

C24H43O6- (427.3059)


   

(1R,9S,10S,11S)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H33N3O4 (427.2471)


   

(1S,9R,10R,11R)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H33N3O4 (427.2471)


   

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

(E,17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoctadec-2-enoate

C24H43O6- (427.3059)


   

[(4R,7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate

[(4R,7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate

C21H33NO8 (427.2206)


   

Pimavanserin

Pimavanserin

C25H34FN3O2 (427.2635)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

Mozavaptan

Mozavaptan

C27H29N3O2 (427.226)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

   

leupeptin(1+)

leupeptin(1+)

C20H39N6O4 (427.3033)


A guanidinium ion that is the conjugate acid of leupeptin, arising from protonation of the guanidino group; major species at pH 7.3.

   

oscr#31(1-)

oscr#31(1-)

C24H43O6 (427.3059)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#31, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#31(1-)

ascr#31(1-)

C24H43O6 (427.3059)


Conjugate base of ascr#31

   

andrastin D(1-)

andrastin D(1-)

C26H35O5 (427.2484)


An enolate anion resulting from the deprotonation of the enol of andrastin D.Major species at pH 7.3. Published in http://dx.doi.org/10.1016/j.tet.2013.07.029

   

Anandamide-O-phosphate

Anandamide-O-phosphate

C22H38NO5P (427.2487)


   

NA-Met 19:1(9Z)

NA-Met 19:1(9Z)

C24H45NO3S (427.312)


   

NA-PABA 20:2(11Z,14Z)

NA-PABA 20:2(11Z,14Z)

C27H41NO3 (427.3086)


   

NA-Phe 18:2(9E,12E)

NA-Phe 18:2(9E,12E)

C27H41NO3 (427.3086)


   

NA-Phe 18:2(9Z,12Z)

NA-Phe 18:2(9Z,12Z)

C27H41NO3 (427.3086)


   

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Val 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C27H41NO3 (427.3086)


   
   
   
   
   

ST 19:1;O6;Gly

ST 19:1;O6;Gly

C21H33NO8 (427.2206)


   

ST 20:0;O5;Gly

ST 20:0;O5;Gly

C22H37NO7 (427.257)


   

ST 23:5;O3;Gly

ST 23:5;O3;Gly

C25H33NO5 (427.2359)


   

ST 24:4;O2;Gly

ST 24:4;O2;Gly

C26H37NO4 (427.2722)


   
   

(5s)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5s)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(1r,2s,4r,5s,8r,9e,11z,13e,15s,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

(1r,2s,4r,5s,8r,9e,11z,13e,15s,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

C25H33NO5 (427.2359)


   

(3s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one

(3s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one

C25H33NO5 (427.2359)


   

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

C27H41NO3 (427.3086)


   

(2r)-n-[(3r)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

(2r)-n-[(3r)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(1s,2s,4s,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

(1s,2s,4s,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

C25H33NO5 (427.2359)


   

3-[2-(but-2-en-2-yl)-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

3-[2-(but-2-en-2-yl)-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

(3r,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one

(3r,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one

C25H33NO5 (427.2359)


   

2-{2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

2-{2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

C27H41NO3 (427.3086)


   

methyl (1s,5s,6r,9s,10s,16r,17r,20r)-9-[(acetyloxy)methyl]-20-hydroxy-5-methyl-3-azahexacyclo[11.5.1.1⁶,¹⁰.0¹,⁹.0²,⁶.0¹⁶,¹⁹]icosa-2,13(19)-diene-17-carboxylate

methyl (1s,5s,6r,9s,10s,16r,17r,20r)-9-[(acetyloxy)methyl]-20-hydroxy-5-methyl-3-azahexacyclo[11.5.1.1⁶,¹⁰.0¹,⁹.0²,⁶.0¹⁶,¹⁹]icosa-2,13(19)-diene-17-carboxylate

C25H33NO5 (427.2359)


   

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(1r,2s,6s,9s,10r,11r,14s,15s,18s,23r,24s)-10-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosane-17,20-dione

(1r,2s,6s,9s,10r,11r,14s,15s,18s,23r,24s)-10-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosane-17,20-dione

C27H41NO3 (427.3086)


   

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1s,4r)-1-methyl-4-[(2s)-6-oxoheptan-2-yl]cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1s,4r)-1-methyl-4-[(2s)-6-oxoheptan-2-yl]cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

C22H37NO7 (427.257)


   

3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

7-(1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one

7-(1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

[5-(5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl)-5,7-dimethyl-6-(prop-1-en-1-yl)-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate

[5-(5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl)-5,7-dimethyl-6-(prop-1-en-1-yl)-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate

C25H33NO5 (427.2359)


   

7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-2-hydroxy-4-methylhept-6-en-3-one

7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

methyl (1r,2r,3r,5r,6s,10s,16r,17r)-2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate

methyl (1r,2r,3r,5r,6s,10s,16r,17r)-2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate

C25H33NO5 (427.2359)


   

7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one

7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(3s,3'r,3'as,4as,6's,6ar,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

(3s,3'r,3'as,4as,6's,6ar,6bs,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]propan-1-one

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]propan-1-one

C27H41NO3 (427.3086)


   

16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

C27H41NO3 (427.3086)


   

(5r)-3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

(5r)-3-[(1s,2r,4ar,6r,8s,8as)-2-[(2e)-but-2-en-2-yl]-3,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-butoxy-5-methylpyrrol-2-ol

C27H41NO3 (427.3086)


   

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

(2r)-2-[(1r,2r,3as,3bs,7s,9ar,9bs,11as)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)propan-1-one

C27H41NO3 (427.3086)


   

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-1-[(4r)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

(5s)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5s)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

2-(1-{7-hydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-1-yl}ethyl)-5-methyl-5,6-dihydro-4h-pyridin-3-one

2-(1-{7-hydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-1-yl}ethyl)-5-methyl-5,6-dihydro-4h-pyridin-3-one

C27H41NO3 (427.3086)


   

(2s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1h,3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,11-diol

C27H41NO3 (427.3086)


   

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(2s,4s,6e)-7-[(1s,3as,4s,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1s,3as,4s,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(3s,6s)-3-({5-[(2s)-2,3-dihydroxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-({5-[(2s)-2,3-dihydroxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol

C24H33N3O4 (427.2471)


   

(2s,4s,6e)-7-[(1s,3ar,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1s,3ar,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(1s,10s,12s,13e,18r)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

(1s,10s,12s,13e,18r)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-18-(methoxycarbonyl)-15-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-trien-15-ium

[C24H31N2O5]+ (427.2233)


   

(1s,13r,14s,17s,19r)-7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),6,9-tetraen-17-yl acetate

(1s,13r,14s,17s,19r)-7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3(11),4(8),6,9-tetraen-17-yl acetate

C25H33NO5 (427.2359)


   

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

C26H37NO4 (427.2722)


   

(2s,4s,6e)-7-[(1as,2r,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1as,2r,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(10s,11r,14s,15r,16s)-14-hydroxy-4-(2-hydroxyethyl)-10,14-dimethyl-10-(4-methylpent-3-en-1-yl)-9,18-dioxa-4-azapentacyclo[13.2.1.0²,⁶.0⁸,¹⁷.0¹¹,¹⁶]octadeca-1(17),2(6),7-trien-5-one

(10s,11r,14s,15r,16s)-14-hydroxy-4-(2-hydroxyethyl)-10,14-dimethyl-10-(4-methylpent-3-en-1-yl)-9,18-dioxa-4-azapentacyclo[13.2.1.0²,⁶.0⁸,¹⁷.0¹¹,¹⁶]octadeca-1(17),2(6),7-trien-5-one

C25H33NO5 (427.2359)


   

3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

(1s,2s,4r,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

(1s,2s,4r,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

C25H33NO5 (427.2359)


   

n-[2-(4-{[(2e)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H33NO5 (427.2359)


   

(1s,13r,14s,17s,19s)-7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate

(1s,13r,14s,17s,19s)-7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate

C25H33NO5 (427.2359)


   

(2s,4s,6e)-7-[(1s,3as,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1s,3as,4r,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(5r)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5r)-3-[(1r,2s,4as,6s,8ar)-2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

(3'ar,4ar,6as,6br,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

(3'ar,4ar,6as,6br,7'ar,9r,11as,11br)-3-hydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO3 (427.3086)


   

n-[2-(4-{[(2e,4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e,4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H33NO5 (427.2359)


   

n-[2-(4-{[(4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(4r,6s)-4,6,7-trihydroxy-3,7-dimethyloct-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H33NO5 (427.2359)


   

7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate

7,10-dihydroxy-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),6,9-tetraen-19-yl acetate

C25H33NO5 (427.2359)


   

7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,6,8,10-tetraen-17-yl acetate

7,10-dihydroxy-1,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,6,8,10-tetraen-17-yl acetate

C25H33NO5 (427.2359)


   

10,16-dihydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl 2-methylbutanoate

10,16-dihydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl 2-methylbutanoate

C25H33NO5 (427.2359)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-3-hydroxy-4-methylhept-6-en-2-one

7-(1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl)-3-hydroxy-4-methylhept-6-en-2-one

C25H33NO5 (427.2359)


   

methyl 2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate

methyl 2-[(acetyloxy)methyl]-6-methyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carboxylate

C25H33NO5 (427.2359)


   

(2e,4e)-16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

(2e,4e)-16-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hexadeca-2,4-dienimidic acid

C27H41NO3 (427.3086)


   

(2s,4s,6e)-7-[(1s,3ar,4r,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1s,3ar,4r,5s,7s,7as)-1-benzyl-3,3a,5-trihydroxy-7-methyl-6-methylidene-4,5,7,7a-tetrahydro-1h-isoindol-4-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(5-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

7-hydroxy-9a,11a-dimethyl-1-[1-(5-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-{[1-methyl-4-(6-oxoheptan-2-yl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-{[1-methyl-4-(6-oxoheptan-2-yl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

C22H37NO7 (427.257)


   

n-[(2s,3r,4r,5s,6r)-2-({1-[(2r,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2-({1-[(2r,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C22H37NO7 (427.257)


   

(1r,2s,4r,5s,8r,9e,11z,13e,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

(1r,2s,4r,5s,8r,9e,11z,13e,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

C25H33NO5 (427.2359)


   

(2s)-n-[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

(2s)-n-[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(1r,3as,3bs,5as,7s,9ar,9br,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

(1r,3as,3bs,5as,7s,9ar,9br,11as)-7-hydroxy-9a,11a-dimethyl-1-[(2s)-1-[(4s)-4-methyl-4,5-dihydro-3h-pyrrol-2-yl]-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-5-one

C27H41NO3 (427.3086)


   

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-6-one

7-hydroxy-9a,11a-dimethyl-1-[1-(4-methyl-4,5-dihydro-3h-pyrrol-2-yl)-1-oxopropan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-6-one

C27H41NO3 (427.3086)


   

7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-3-hydroxy-4-methylhept-6-en-2-one

7-{5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl}-3-hydroxy-4-methylhept-6-en-2-one

C25H33NO5 (427.2359)


   

(13e)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

(13e)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one

C25H33NO5 (427.2359)


   

(3r,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-3-hydroxy-4-methylhept-6-en-2-one

(3r,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-3-hydroxy-4-methylhept-6-en-2-one

C25H33NO5 (427.2359)


   

n-(2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl)-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

n-(2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl)-2-(n-methyldec-9-enamido)-3-phenylpropanimidic acid

C25H37N3O3 (427.2835)


   

(5r)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

(5r)-3-[(1r,2s,4as,6s,8ar)-2-[(2e)-but-2-en-2-yl]-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1h-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

C27H41NO3 (427.3086)


   

3-{[5-(2,3-dihydroxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol

3-{[5-(2,3-dihydroxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol

C24H33N3O4 (427.2471)


   

n-[(2s,3r,4r,5s,6r)-2-({1-[(2s,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2-({1-[(2s,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C22H37NO7 (427.257)


   

4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate

C25H33NO5 (427.2359)


   

(2s,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one

(2s,4s,6e)-7-[(1as,2s,2as,5s,5as,6s,6ar)-5-benzyl-2a,3-dihydroxy-6,6a-dimethyl-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2-hydroxy-4-methylhept-6-en-3-one

C25H33NO5 (427.2359)


   

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,10r,11ar,11br)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,10-diol

(3s,3'r,3'as,6's,6as,6bs,7'ar,9r,10r,11ar,11br)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3,10-diol

C27H41NO3 (427.3086)


   

[(2s,4ar,5s,6r,8as)-5-[(5z)-5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl]-5,7-dimethyl-6-[(1e)-prop-1-en-1-yl]-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate

[(2s,4ar,5s,6r,8as)-5-[(5z)-5-ethylidene-2,4-dihydroxypyrrole-3-carbonyl]-5,7-dimethyl-6-[(1e)-prop-1-en-1-yl]-2,3,4,4a,6,8a-hexahydro-1h-naphthalen-2-yl]methyl acetate

C25H33NO5 (427.2359)